XML 118 R101.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation and Other Incentive Plans - Options, Performance Options, RSUs, and Market Stock Units (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2024
$ / shares
shares
No. of Options Outstanding  
Balance at end of period (in shares) 2,222
Awards exercisable (in shares) 1,674
Stock Options  
No. of Options Outstanding  
Balance at end of period (in shares) 566
Granted (in shares) 106
Releases/Exercised (in shares) (175)
Forfeited/Canceled (in shares) (6)
Balance at end of period (in shares) 491
Awards exercisable (in shares) 275
Wtd. Avg. Exercise Price of Shares  
Balance at end of period (USD per share) | $ / shares $ 191
Granted (USD per share) | $ / shares 360
Releases/Exercised (USD per share) | $ / shares 175
Forfeited/Canceled (USD per share) | $ / shares 314
Balance at end of period (USD per share) | $ / shares 230
Awards exercisable (USD per share) | $ / shares $ 174
Restricted Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 1,342
Granted (in shares) 582
Releases/Exercised (in shares) (601)
Forfeited/Canceled (in shares) (48)
Balance at end of period (in shares) 1,275
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 224
Granted (USD per share) | $ / shares 340
Releases/Exercised (USD per share) | $ / shares 225
Forfeited/Canceled (USD per share) | $ / shares 268
Outstanding at end of period (USD per share) | $ / shares 275
Awards exercisable (USD per share) | $ / shares $ 0
Restricted Stock  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 85
Granted (in shares) 65
Releases/Exercised (in shares) (85)
Forfeited/Canceled (in shares) 0
Balance at end of period (in shares) 65
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 244
Granted (USD per share) | $ / shares 397
Releases/Exercised (USD per share) | $ / shares 244
Forfeited/Canceled (USD per share) | $ / shares 0
Outstanding at end of period (USD per share) | $ / shares 397
Awards exercisable (USD per share) | $ / shares $ 0
Performance Options  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 1,798
Granted (in shares) 104
Releases/Exercised (in shares) (316)
Adjustment for payout factor (in shares) 147
Forfeited/Canceled (in shares) (2)
Balance at end of period (in shares) 1,731
Awards exercisable (in shares) 1,399
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 122
Granted (USD per share) | $ / shares 343
Releases/Exercised (USD per share) | $ / shares 101
Adjustment for payout factor (USD per share) | $ / shares 179
Forfeited/Canceled (USD per share) | $ / shares 179
Outstanding at end of period (USD per share) | $ / shares 144
Awards exercisable (USD per share) | $ / shares $ 113
Market Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 89
Granted (in shares) 37
Releases/Exercised (in shares) (69)
Adjustment for payout factor (in shares) 23
Forfeited/Canceled (in shares) (1)
Balance at end of period (in shares) 79
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 254
Granted (USD per share) | $ / shares 397
Releases/Exercised (USD per share) | $ / shares 230
Adjustment for payout factor (USD per share) | $ / shares 179
Forfeited/Canceled (USD per share) | $ / shares 185
Outstanding at end of period (USD per share) | $ / shares 331
Awards exercisable (USD per share) | $ / shares $ 0
Performance Stock Units  
No. of Non-Vested Awards  
Balance at beginning of period (in shares) 213
Granted (in shares) 132
Releases/Exercised (in shares) (147)
Adjustment for payout factor (in shares) 74
Forfeited/Canceled (in shares) (8)
Balance at end of period (in shares) 264
Awards exercisable (in shares) 0
Wtd. Avg. Grant Date Fair Value  
Outstanding at beginning of period (USD per share) | $ / shares $ 264
Granted (USD per share) | $ / shares 514
Releases/Exercised (USD per share) | $ / shares 335
Adjustment for payout factor (USD per share) | $ / shares 321
Forfeited/Canceled (USD per share) | $ / shares 316
Outstanding at end of period (USD per share) | $ / shares 407
Awards exercisable (USD per share) | $ / shares $ 0